molecular diagnostics
Through detailed molecular diagnosis, subgroups of diseases can be defined and targeted treatments can be developed. For example, it is thus possible to treat patients with cancer or autoimmune diseases with very specific acting therapeutic antibodies.
The company BioTeZ Berlin-Buch GmbH has developed a monitoring system with which for the first time physicians can determine during treatment what effect the drug has on the individual patient and what dosage he/she still needs. Thus, the treatment can be optimized for the individual patient, which may in the end also be much more cost effective.
INVITEK Molecular GmbH offers customized solutions for the manual and automatic preparation of samples for molecular biological diagnostic methods, such as DNA and RNA analysis. Nucleic acid isolation and purification are offered by IST Innuscreen GmbH. The company’s portfolio also includes molecular biological reagent systems as well as technologies and products for molecular diagnostics.
Molecular diagnostics also have applications in food technology: The company aokin AG is specialized in rapid precision analysis of toxins: With the aokin system, mold in grain shipments can be identified within minutes. Congen Biotechnologie GmbH develops and produces PCR-based detection methods for agricultural and food analysis. This makes it possible to identify genetically modified plants, allergens or pathogenic bacteria and viruses.
News innovation
Eckert & Ziegler Selected as US Manufacturer for Archeus’ Next-Generation Radiopharmaceutical ART-101
Eckert & Ziegler (ISIN DE0005659700) has entered a Master Service Agreement with Archeus Technologies (Archeus), a company developing multiple differentiated radiopharmaceutical therapies, for contrac...
more ...Eckert & Ziegler: Capital Increase Entered in the Commercial Register. Share Split in Preparation.
The Annual General Meeting of Eckert & Ziegler SE (ISIN DE0005659700) resolved on June 18, 2025, to increase the share capital using company funds by € 42,343,864 to € 63,515,796.
more ...Eckert & Ziegler: Outstanding Training Quality Once Again Awarded
Eckert & Ziegler SE (ISIN DE0005659700) has been recognized by the Berlin Chamber of Industry and Commerce (IHK) for the exceptional quality of its training program for the fourth time in a row.
more ...Events Campus
09.09.2025, 09:00
From Target to Market - The BBA Biotech & Pharma Summer School
The 4-day intensive course provides a comprehensive overview of the entire drug development process in biotechnology and in the pharmaceutical industry – from the idea to the market.
more ...14.09.2025, 11:00
Tag des offenen Denkmals - Einladung auf den Wissenschaftscampus Berlin-Buch
Offenes Wissenschaftsmuseum und Führung zur Geschichte des Campus Berlin-Buch
more ...18.09.2025, 17:00
Talk im Cube: IP Strategies in Biotechnology
We are excited to continue the Talks in the Cube with a further expert discussion focused on Strategies for Intellectual Property Rights in Biotechnology.
more ...
